Barely Significant
← all phrases

“an observed trend”

505 sentences · 505 papers · 14,217 search hits before verification · confirmed specimen

Sighted at

p=0.06

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

Similarly, there was an observed trend indicating that patients with PA with posttreatment PRA levels between 1 and 2 ng/mL per hour had a lower incidence of MACE compared with those with PRA levels either <1 ng/mL per hour or >2 ng/mL per hour; however, this trend also did not reach statistical significance.
Furthermore, there is an observed trend for better survival in NB patients with high TRIM36 expression indicated by bioinformatic analysis of public available Kocak datasets, which were obtained from the R2 Genomics Analysis and Visualization Platform ( http://r2.amc.nl ) ( Figure 2 ).
TRIM proteins in neuroblastoma.
Biosci Rep · 2019 · PMC6928532
Several prior published studies show a limited impact of injection rate without clinically significant differences for subject VAS pain perception and others an observed trend toward lower VAS scores at slower rates. 17 , 21 , 30 , 35 , 37 , 41 , 42 LVSC administrations up to 600 ml have previously been well‐tolerated when co‐delivered with permeation enhancers, such as recombinant human hyaluronidase. 1 , 29 The current study used a s
How such an observed trend translates to long-term clinical outcomes for younger Black men remains to be seen. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY Prostate cancer is the most common noncutaneous malignancy affecting men in the United States ( 1 ).
After a median follow-up of 17 (placebo) to 21 (cinacalcet) months, there was an observed trend for relative reduction in the HR for the primary composite CV outcome (i.e., time until death, myocardial infarction, hospitalization for unstable angina, heart failure, or a peripheral vascular event) (HR: 0.93; 95% CI: 0.85 to 1.02; p = 0.11).
Targeting Vascular Calcification in Chronic Kidney Disease.
JACC Basic Transl Sci · 2020 · PMC7188874
On the basis of an observed trend towards increased survival with the combination of isosorbide dintrate and hydralazine in patients with HFrEF in the Vasodilator Heart Failure Trial (V-HeFT) 1986, the V-HeFT II trial (1992), randomized patients with primarily NYHA II-III HFrEF on diuretics and digoxin at baseline to enalapril or isosorbide dintrate/hydralazine.